Cargando…

Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators

BACKGROUND: In Kenya, people who inject drugs (PWID) are disproportionately affected by HIV and hepatitis C (HCV) epidemics, including HIV-HCV coinfections; however, few have assessed factors affecting their access to and engagement in care through the lens of community-embedded, peer educators. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ludwig-Barron, Natasha T., Guthrie, Brandon L., Mbogo, Loice, Bukusi, David, Sinkele, William, Gitau, Esther, Farquhar, Carey, Monroe-Wise, Aliza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684158/
https://www.ncbi.nlm.nih.gov/pubmed/34922548
http://dx.doi.org/10.1186/s12954-021-00580-7
_version_ 1784617560308711424
author Ludwig-Barron, Natasha T.
Guthrie, Brandon L.
Mbogo, Loice
Bukusi, David
Sinkele, William
Gitau, Esther
Farquhar, Carey
Monroe-Wise, Aliza
author_facet Ludwig-Barron, Natasha T.
Guthrie, Brandon L.
Mbogo, Loice
Bukusi, David
Sinkele, William
Gitau, Esther
Farquhar, Carey
Monroe-Wise, Aliza
author_sort Ludwig-Barron, Natasha T.
collection PubMed
description BACKGROUND: In Kenya, people who inject drugs (PWID) are disproportionately affected by HIV and hepatitis C (HCV) epidemics, including HIV-HCV coinfections; however, few have assessed factors affecting their access to and engagement in care through the lens of community-embedded, peer educators. This qualitative study leverages the personal and professional experiences of peer educators to help identify HIV and HCV barriers and facilitators to care among PWID in Nairobi, including resource recommendations to improve service uptake. METHODS: We recruited peer educators from two harm reduction facilities in Nairobi, Kenya, using random and purposive sampling techniques. Semi-structured interviews explored circumstances surrounding HIV and HCV service access, prevention education and resource recommendations. A thematic analysis was conducted using the Modified Social Ecological Model (MSEM) as an underlying framework, with illustrative quotes highlighting emergent themes. RESULTS: Twenty peer educators participated, including six women, with 2-months to 6-years of harm reduction service. Barriers to HIV and HCV care were organized by (a) individual-level themes including the competing needs of addiction and misinterpreted symptoms; (b) social network-level themes including social isolation and drug dealer interactions; (c) community-level themes including transportation, mental and rural healthcare services, and limited HCV resources; and (d) policy-level themes including nonintegrated health services, clinical administration, and law enforcement. Stigma, an overarching barrier, was highlighted throughout the MSEM. Facilitators to HIV and HCV care were comprised of (a) individual-level themes including concurrent care, personal reflections, and religious beliefs; (b) social network-level themes including community recommendations, navigation services, family commitment, and employer support; (c) community-level themes including quality services, peer support, and outreach; and (d) policy-level themes including integrated health services and medicalized approaches within law enforcement. Participant resource recommendations include (i) additional medical, social and ancillary support services, (ii) national strategies to address stigma and violence and (iii) HCV prevention education. CONCLUSIONS: Peer educators provided intimate knowledge of PWID barriers and facilitators to HIV and HCV care, described at each level of the MSEM, and should be given careful consideration when developing future initiatives. Recommendations emphasized policy and community-level interventions including educational campaigns and program suggestions to supplement existing HIV and HCV services.
format Online
Article
Text
id pubmed-8684158
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86841582021-12-20 Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators Ludwig-Barron, Natasha T. Guthrie, Brandon L. Mbogo, Loice Bukusi, David Sinkele, William Gitau, Esther Farquhar, Carey Monroe-Wise, Aliza Harm Reduct J Research BACKGROUND: In Kenya, people who inject drugs (PWID) are disproportionately affected by HIV and hepatitis C (HCV) epidemics, including HIV-HCV coinfections; however, few have assessed factors affecting their access to and engagement in care through the lens of community-embedded, peer educators. This qualitative study leverages the personal and professional experiences of peer educators to help identify HIV and HCV barriers and facilitators to care among PWID in Nairobi, including resource recommendations to improve service uptake. METHODS: We recruited peer educators from two harm reduction facilities in Nairobi, Kenya, using random and purposive sampling techniques. Semi-structured interviews explored circumstances surrounding HIV and HCV service access, prevention education and resource recommendations. A thematic analysis was conducted using the Modified Social Ecological Model (MSEM) as an underlying framework, with illustrative quotes highlighting emergent themes. RESULTS: Twenty peer educators participated, including six women, with 2-months to 6-years of harm reduction service. Barriers to HIV and HCV care were organized by (a) individual-level themes including the competing needs of addiction and misinterpreted symptoms; (b) social network-level themes including social isolation and drug dealer interactions; (c) community-level themes including transportation, mental and rural healthcare services, and limited HCV resources; and (d) policy-level themes including nonintegrated health services, clinical administration, and law enforcement. Stigma, an overarching barrier, was highlighted throughout the MSEM. Facilitators to HIV and HCV care were comprised of (a) individual-level themes including concurrent care, personal reflections, and religious beliefs; (b) social network-level themes including community recommendations, navigation services, family commitment, and employer support; (c) community-level themes including quality services, peer support, and outreach; and (d) policy-level themes including integrated health services and medicalized approaches within law enforcement. Participant resource recommendations include (i) additional medical, social and ancillary support services, (ii) national strategies to address stigma and violence and (iii) HCV prevention education. CONCLUSIONS: Peer educators provided intimate knowledge of PWID barriers and facilitators to HIV and HCV care, described at each level of the MSEM, and should be given careful consideration when developing future initiatives. Recommendations emphasized policy and community-level interventions including educational campaigns and program suggestions to supplement existing HIV and HCV services. BioMed Central 2021-12-18 /pmc/articles/PMC8684158/ /pubmed/34922548 http://dx.doi.org/10.1186/s12954-021-00580-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ludwig-Barron, Natasha T.
Guthrie, Brandon L.
Mbogo, Loice
Bukusi, David
Sinkele, William
Gitau, Esther
Farquhar, Carey
Monroe-Wise, Aliza
Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators
title Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators
title_full Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators
title_fullStr Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators
title_full_unstemmed Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators
title_short Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators
title_sort barriers and facilitators of hiv and hepatitis c care among people who inject drugs in nairobi, kenya: a qualitative study with peer educators
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684158/
https://www.ncbi.nlm.nih.gov/pubmed/34922548
http://dx.doi.org/10.1186/s12954-021-00580-7
work_keys_str_mv AT ludwigbarronnatashat barriersandfacilitatorsofhivandhepatitisccareamongpeoplewhoinjectdrugsinnairobikenyaaqualitativestudywithpeereducators
AT guthriebrandonl barriersandfacilitatorsofhivandhepatitisccareamongpeoplewhoinjectdrugsinnairobikenyaaqualitativestudywithpeereducators
AT mbogoloice barriersandfacilitatorsofhivandhepatitisccareamongpeoplewhoinjectdrugsinnairobikenyaaqualitativestudywithpeereducators
AT bukusidavid barriersandfacilitatorsofhivandhepatitisccareamongpeoplewhoinjectdrugsinnairobikenyaaqualitativestudywithpeereducators
AT sinkelewilliam barriersandfacilitatorsofhivandhepatitisccareamongpeoplewhoinjectdrugsinnairobikenyaaqualitativestudywithpeereducators
AT gitauesther barriersandfacilitatorsofhivandhepatitisccareamongpeoplewhoinjectdrugsinnairobikenyaaqualitativestudywithpeereducators
AT farquharcarey barriersandfacilitatorsofhivandhepatitisccareamongpeoplewhoinjectdrugsinnairobikenyaaqualitativestudywithpeereducators
AT monroewisealiza barriersandfacilitatorsofhivandhepatitisccareamongpeoplewhoinjectdrugsinnairobikenyaaqualitativestudywithpeereducators